234 related articles for article (PubMed ID: 8167728)
1. Chronic granulomatous disease: towards gene therapy.
Thrasher A; Segal A; Casimir C
Immunodeficiency; 1993; 4(1-4):327-33. PubMed ID: 8167728
[TBL] [Abstract][Full Text] [Related]
2. Restoration of superoxide generation to a chronic granulomatous disease-derived B-cell line by retrovirus mediated gene transfer.
Thrasher A; Chetty M; Casimir C; Segal AW
Blood; 1992 Sep; 80(5):1125-9. PubMed ID: 1325210
[TBL] [Abstract][Full Text] [Related]
3. NADPH oxidase activity and cytochrome b558 content of human Epstein-Barr-virus-transformed B lymphocytes correlate with expression of genes encoding components of the oxidase system.
Condino-Neto A; Newburger PE
Arch Biochem Biophys; 1998 Dec; 360(2):158-64. PubMed ID: 9851826
[TBL] [Abstract][Full Text] [Related]
4. In vitro molecular reconstitution of the respiratory burst in B lymphoblasts from p47-phox-deficient chronic granulomatous disease.
Volpp BD; Lin Y
J Clin Invest; 1993 Jan; 91(1):201-7. PubMed ID: 7678602
[TBL] [Abstract][Full Text] [Related]
5. Homologous dinucleotide (GT or TG) deletion in Japanese patients with chronic granulomatous disease with p47-phox deficiency.
Iwata M; Nunoi H; Yamazaki H; Nakano T; Niwa H; Tsuruta S; Ohga S; Ohmi S; Kanegasaki S; Matsuda I
Biochem Biophys Res Commun; 1994 Mar; 199(3):1372-7. PubMed ID: 8147881
[TBL] [Abstract][Full Text] [Related]
6. Is the IFN-gamma-induced enhancement of superoxide production in CGD-phagocytes caused by increased expression of the p47-phox cytosolic protein.
Jendrossek V; Damm U; Liese J; Belohradsky BH; Gahr M
Immunodeficiency; 1993; 4(1-4):187-90. PubMed ID: 8167697
[TBL] [Abstract][Full Text] [Related]
7. A point mutation in gp91-phox of cytochrome b558 of the human NADPH oxidase leading to defective translocation of the cytosolic proteins p47-phox and p67-phox.
Leusen JH; de Boer M; Bolscher BG; Hilarius PM; Weening RS; Ochs HD; Roos D; Verhoeven AJ
J Clin Invest; 1994 May; 93(5):2120-6. PubMed ID: 8182143
[TBL] [Abstract][Full Text] [Related]
8. Genetic and biochemical background of chronic granulomatous disease.
Jurkowska M; Bernatowska E; Bal J
Arch Immunol Ther Exp (Warsz); 2004; 52(2):113-20. PubMed ID: 15179325
[TBL] [Abstract][Full Text] [Related]
9. [Gene therapy for inherited diseases using heamatopoietic stem cells--gene therapy for patients with chronic granulomatous disease].
Nunoi H; Ishibashi F
Hum Cell; 1999 Sep; 12(3):103-8. PubMed ID: 10695016
[TBL] [Abstract][Full Text] [Related]
10. Retroviral expression of recombinant p47phox protein by Epstein-Barr virus-transformed B lymphocytes from a patient with autosomal chronic granulomatous disease.
Cobbs CS; Malech HL; Leto TL; Freeman SM; Blaese RM; Gallin JI; Lomax KJ
Blood; 1992 Apr; 79(7):1829-35. PubMed ID: 1313715
[TBL] [Abstract][Full Text] [Related]
11. Gene therapy for chronic granulomatous disease.
Kume A; Dinauer MC
J Lab Clin Med; 2000 Feb; 135(2):122-8. PubMed ID: 10695656
[TBL] [Abstract][Full Text] [Related]
12. Enhancer-deleted retroviral vectors restore high levels of superoxide generation in a mouse model of CGD.
Schwickerath O; Brouns G; Thrasher A; Kinnon C; Roes J; Casimir C
J Gene Med; 2004 Jun; 6(6):603-15. PubMed ID: 15170731
[TBL] [Abstract][Full Text] [Related]
13. Molecular basis of the autosomal recessive forms of chronic granulomatous disease.
Curnutte JT
Immunodefic Rev; 1992; 3(2):149-72. PubMed ID: 1554499
[TBL] [Abstract][Full Text] [Related]
14. Partial reconstitution of the respiratory burst oxidase in lymphoblastoid B cell lines lacking p67-phox after transfection with an expression vector containing wild-type and mutant p67 -phox cDNAs: Deletions of the carboxy and amino terminal residues of p67-phox are not required for activity.
Chanock SJ; Faust LR; Barrett D; Christensen B; Newburger PE; Babior BM
Exp Hematol; 1996 Mar; 24(4):531-6. PubMed ID: 8608803
[TBL] [Abstract][Full Text] [Related]
15. Functional reconstitution of oxidase activity in X-linked chronic granulomatous disease by retrovirus-mediated gene transfer.
Zentilin L; Tafuro S; Grassi G; Garcia R; Ventura A; Baralle F; Falaschi A; Giacca M
Exp Cell Res; 1996 Jun; 225(2):257-67. PubMed ID: 8660913
[TBL] [Abstract][Full Text] [Related]
16. A novel and unusual case of chronic granulomatous disease in a child with a homozygous 36-bp deletion in the CYBA gene (A22(0)) leading to the activation of a cryptic splice site in intron 4.
Stasia MJ; Bordigoni P; Martel C; Morel F
Hum Genet; 2002 May; 110(5):444-50. PubMed ID: 12073015
[TBL] [Abstract][Full Text] [Related]
17. [Statistical evaluation of chronic granulomatous disease in Japan and basic studies for gene therapy for CGD patients].
Nunoi H; Ishibashi F
Rinsho Byori; 1999 Jul; 47(7):658-64. PubMed ID: 10442045
[TBL] [Abstract][Full Text] [Related]
18. Progress in gene therapy for chronic granulomatous disease.
Malech HL
J Infect Dis; 1999 Mar; 179 Suppl 2():S318-25. PubMed ID: 10081502
[TBL] [Abstract][Full Text] [Related]
19. The superoxide generating system of B cell lines. Structural homology with the phagocytic oxidase and triggering via surface Ig.
Maly FE; Cross AR; Jones OT; Wolf-Vorbeck G; Walker C; Dahinden CA; De Weck AL
J Immunol; 1988 Apr; 140(7):2334-9. PubMed ID: 2832475
[TBL] [Abstract][Full Text] [Related]
20. Genomic structure of the human p47-phox (NCF1) gene.
Chanock SJ; Roesler J; Zhan S; Hopkins P; Lee P; Barrett DT; Christensen BL; Curnutte JT; Görlach A
Blood Cells Mol Dis; 2000 Feb; 26(1):37-46. PubMed ID: 10772875
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
